Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-tert-Butylbenzenesulfonamide is an organic compound that serves as an intermediate and a degradation impurity in the synthesis of the endothelin receptor antagonist Bosentan (B675900). It is characterized by its white solid appearance and is utilized in the pharmaceutical industry for the development and production of certain medications.

6292-59-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 6292-59-7 Structure
  • Basic information

    1. Product Name: 4-tert-Butylbenzenesulfonamide
    2. Synonyms: BUTTPARK 44\03-78;4-TERT-BUTYLBENZENESULFONAMIDE;4-TERT-BUTYLBENZENESULPHONAMIDE;4-(TERT-BUTYL)BENZENE-1-SULFONAMIDE;P-TERT-BUTYL-BENZENESULFONAMIDE;TertiaryButylBenzeneSulphonamide;4-(1,1-DIMETHYLETHYL)BENZENESULFONAMIDE;4-TERT-BUTYLBENZENESULFONAMIDE (SEE 5062)
    3. CAS NO:6292-59-7
    4. Molecular Formula: C10H15NO2S
    5. Molecular Weight: 213.3
    6. EINECS: 1308068-626-2
    7. Product Categories: Aromatics;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals
    8. Mol File: 6292-59-7.mol
  • Chemical Properties

    1. Melting Point: 136-138°C
    2. Boiling Point: 337.2 °C at 760 mmHg
    3. Flash Point: 157.7 °C
    4. Appearance: /
    5. Density: 1.152 g/cm3
    6. Vapor Pressure: 0.000107mmHg at 25°C
    7. Refractive Index: 1.536
    8. Storage Temp.: Sealed in dry,Room Temperature
    9. Solubility: Chloroform (Slightly), Ethyl Acetate (Sparingly)
    10. PKA: 10.22±0.10(Predicted)
    11. CAS DataBase Reference: 4-tert-Butylbenzenesulfonamide(CAS DataBase Reference)
    12. NIST Chemistry Reference: 4-tert-Butylbenzenesulfonamide(6292-59-7)
    13. EPA Substance Registry System: 4-tert-Butylbenzenesulfonamide(6292-59-7)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 20/21/22
    3. Safety Statements: 22-36/37/39
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 6292-59-7(Hazardous Substances Data)

6292-59-7 Usage

Uses

Used in Pharmaceutical Industry:
4-tert-Butylbenzenesulfonamide is used as an intermediate in the synthesis of Bosentan, a medication that acts as an endothelin receptor antagonist. It is particularly effective in treating pulmonary arterial hypertension and digital ulcers associated with systemic sclerosis.
Additionally, as a degradation impurity, 4-tert-Butylbenzenesulfonamide plays a role in the stability and quality control of Bosentan, ensuring the drug's efficacy and safety for patients.

Check Digit Verification of cas no

The CAS Registry Mumber 6292-59-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,9 and 2 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6292-59:
(6*6)+(5*2)+(4*9)+(3*2)+(2*5)+(1*9)=107
107 % 10 = 7
So 6292-59-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO2S/c1-10(2,3)8-4-6-9(7-5-8)14(11,12)13/h4-7H,1-3H3,(H2,11,12,13)

6292-59-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1076160)  Bosentan Related Compound E  United States Pharmacopeia (USP) Reference Standard

  • 6292-59-7

  • 1076160-15MG

  • 14,578.20CNY

  • Detail

6292-59-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Tert-Butylbenzenesulfonamide

1.2 Other means of identification

Product number -
Other names 4-Tert-butylbenzenesulfonamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6292-59-7 SDS

6292-59-7Synthetic route

4-tert-butylbenzenesulfonyl chloride
15084-51-2

4-tert-butylbenzenesulfonyl chloride

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With ammonium hydroxide for 72h; Ambient temperature;99%
With ammonium hydroxide In ethyl acetate at 20℃; for 1h;95%
With ammonium hydroxide In acetone at 20℃;94%
4,N-di-tert-butyl-benzenesulfonamide

4,N-di-tert-butyl-benzenesulfonamide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With scandium tris(trifluoromethanesulfonate) In nitromethane at 50℃; for 5h;96%
4-tert-Butyl-N-isopropyl-benzenesulfonamide
5636-16-8

4-tert-Butyl-N-isopropyl-benzenesulfonamide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With chromium(III) acetate hydroxide; periodic acid In acetonitrile at 20℃; for 14h;94%
(4-tert-butylphenyl)diazonium tetrafluoroborate
52436-75-6

(4-tert-butylphenyl)diazonium tetrafluoroborate

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With sodium metabisulfite; sodium azide; tetrabutylammomium bromide; triphenylphosphine In water; acetonitrile at 80℃; for 12h; Inert atmosphere;84%
With sodium metabisulfite; sodium azide; tetrabutylammomium bromide; triphenylphosphine In water; acetonitrile at 80℃; for 12h; Inert atmosphere; Schlenk technique;84%
4-(tert-butyl)-N,N-diethylbenzenesulfonamide

4-(tert-butyl)-N,N-diethylbenzenesulfonamide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With chromium(III) acetate hydroxide; periodic acid In acetonitrile at 20℃; for 16h;81%
4-t-butylbenzenethiol
2396-68-1

4-t-butylbenzenethiol

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With [bis(acetoxy)iodo]benzene; ammonium carbamate In methanol at 25℃; for 24h; Inert atmosphere; chemoselective reaction;80%
potassium tert-butyltrifluoroboranuide

potassium tert-butyltrifluoroboranuide

4-bromo-benzenesulfonic acid amide
701-34-8

4-bromo-benzenesulfonic acid amide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
With dipotassium hydrogenphosphate; nickel(II) bis(2,2,6,6-tetramethylheptane-3,5-dionate); Ir(dF(CF3)ppy)2(bpy)PF6; zinc dibromide In N,N-dimethyl acetamide at 27℃; for 72h; Inert atmosphere; Irradiation;44%
1-tert-butyl-benzene-sulfonyl chloride-(4)

1-tert-butyl-benzene-sulfonyl chloride-(4)

ammonium carbonate

ammonium carbonate

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

tert-butylbenzene
253185-03-4, 253185-04-5

tert-butylbenzene

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: chlorosulfonic acid / 6 h / Reflux
2: ethanol / 1 h / 0 °C
View Scheme
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide
150727-06-3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide

Conditions
ConditionsYield
Stage #1: 4-tert-butylbenzenesulphonamide; 4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine With potassium carbonate In acetonitrile at 25 - 83℃; Large scale reaction;
Stage #2: Large scale reaction;
100%
With potassium carbonate In dimethyl sulfoxide at 100 - 105℃;100%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium carbonate In toluene at 50℃; for 0.5h; Large scale;
Stage #2: 4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine With tetrabutylammomium bromide In toluene at 110℃; for 10h; Large scale;
97%
4-(2-tert-butoxyethoxy)-5-(2-methoxyphenoxy)-6-chloro-2,2'-bipyrimidine
1177447-87-8

4-(2-tert-butoxyethoxy)-5-(2-methoxyphenoxy)-6-chloro-2,2'-bipyrimidine

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

N-[6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide

N-[6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-4-(1,1-dimethylethyl)benzenesulfonamide

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 120℃; for 10h;100%
4-methoxyphenethyl bromide
14425-64-0

4-methoxyphenethyl bromide

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

C19H22O3S

C19H22O3S

Conditions
ConditionsYield
With aluminum (III) chloride; trifluorormethanesulfonic acid; niobium pentachloride; bis-[(trifluoroacetoxy)iodo]benzene; zinc(II) iodide In N,N-dimethyl acetamide at 75℃; for 2.5h; Solvent; Reagent/catalyst;97.3%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-tert-butylbenzenesulfonamide monosodium salt

4-tert-butylbenzenesulfonamide monosodium salt

Conditions
ConditionsYield
With sodium ethanolate for 2h; Heating;97%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

C15H11ClN4O3
1268612-27-6

C15H11ClN4O3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide
150727-06-3

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-yl)benzene sulfonamide

Conditions
ConditionsYield
Stage #1: 4-tert-butylbenzenesulphonamide With potassium carbonate In toluene at 50℃; for 0.5h; Large scale;
Stage #2: C15H11ClN4O3 In toluene at 110℃; for 10h; Large scale;
97%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine

4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide potassium salt

4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzene sulfonamide potassium salt

Conditions
ConditionsYield
Stage #1: 4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine With potassium carbonate for 0.25h;
Stage #2: 4-tert-butylbenzenesulphonamide at 140℃; for 3h; Solvent; Temperature; Time;
96.2%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium hydroxide In acetone at 30℃; for 0.0833333h;
Stage #2: 4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine In acetone at 30℃; for 6.5h; Product distribution / selectivity; Reflux;
89%
With tetrabutylammomium bromide; potassium carbonate In toluene for 10h; Reflux;87.7%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-tert-butylbenzenesulfonamide-d2
1089215-18-8

4-tert-butylbenzenesulfonamide-d2

Conditions
ConditionsYield
With water-d2 In diethyl ether96%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

benzaldehyde
100-52-7

benzaldehyde

N-benzylidene-4-(tert-butyl)benzenesulfonamide

N-benzylidene-4-(tert-butyl)benzenesulfonamide

Conditions
ConditionsYield
With boron trifluoride diethyl etherate In benzene for 12h; Reflux;95%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
150728-13-5

4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine

4-(tert-butyl)-N-(6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidine)-4-yl)benzenesulfonamide sodium salt

4-(tert-butyl)-N-(6-chloro-5-(2-methoxyphenoxy)-(2,2'-bipyrimidine)-4-yl)benzenesulfonamide sodium salt

Conditions
ConditionsYield
With sodium carbonate In dimethyl sulfoxide at 70 - 80℃; for 10h; Reagent/catalyst; Solvent; Temperature;95%
1-phenylpyrrolidin-2-one
4641-57-0

1-phenylpyrrolidin-2-one

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

(E)-4-(tert-butyl)-N-(1-phenylpyrrolidin-2-ylidene)benzenesulfonamide

(E)-4-(tert-butyl)-N-(1-phenylpyrrolidin-2-ylidene)benzenesulfonamide

Conditions
ConditionsYield
With diazoacetic acid ethyl ester; zinc trifluoromethanesulfonate In cyclohexane for 12h; Reflux; stereoselective reaction;94%
N-methylcyclohexylamine
626-67-5

N-methylcyclohexylamine

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-(tert-butyl)-N-(piperidin-1-ylmethylene)benzenesulfonamide

4-(tert-butyl)-N-(piperidin-1-ylmethylene)benzenesulfonamide

Conditions
ConditionsYield
With tetra-(n-butyl)ammonium iodide In ethanol at 20℃; for 12h; Electrochemical reaction; Inert atmosphere; regioselective reaction;94%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-methylphenylboronic acid
5720-05-8

4-methylphenylboronic acid

benzaldehyde
100-52-7

benzaldehyde

(R)-4-(tert-butyl)-N-(phenyl(p-tolyl)methyl)benzenesulfonamide

(R)-4-(tert-butyl)-N-(phenyl(p-tolyl)methyl)benzenesulfonamide

Conditions
ConditionsYield
With palladium(II) trifluoroacetate; (S,S)-4,4′-diisopropyl-4,5,4′,5′-tetrahydro[2.2]bioxazolyl In nitromethane at 40℃; for 64h; enantioselective reaction;93%
2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester
1160515-46-7

2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

2-[6-(4-tert-butyl-benzenesulfonylamino)-5-(2-methoxy-phenoxy)-[2,2']bipyrimidinyl-4-yloxy]-ethanol acetyl ester
1160515-53-6

2-[6-(4-tert-butyl-benzenesulfonylamino)-5-(2-methoxy-phenoxy)-[2,2']bipyrimidinyl-4-yloxy]-ethanol acetyl ester

Conditions
ConditionsYield
Stage #1: 4-tert-butylbenzenesulphonamide With potassium phosphate In N,N-dimethyl acetamide at 75 - 80℃; for 0.5h;
Stage #2: 2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester In N,N-dimethyl acetamide at 65 - 70℃; for 96h; Product distribution / selectivity;
92%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium carbonate In N,N-dimethyl acetamide; acetonitrile at 75 - 80℃; for 0.5h;
Stage #2: 2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester In N,N-dimethyl acetamide; acetonitrile at 65 - 70℃; for 96h; Product distribution / selectivity;
75%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium carbonate In dimethyl sulfoxide at 75 - 80℃; for 0.5h;
Stage #2: 2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester In dimethyl sulfoxide at 65 - 70℃; for 96h; Product distribution / selectivity;
60%
Stage #1: 4-tert-butylbenzenesulphonamide With potassium phosphate In N,N-dimethyl acetamide at 75 - 80℃; for 0.5h;
Stage #2: 2-(5-(2-methoxy-phenoxy)-6-chloro-2-(pyrimidin-2-yl)pyrimidin-4-yloxy)ethanol acetyl ester In ISOPROPYLAMIDE at 65 - 70℃; for 96h; Product distribution / selectivity;
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

acetonitrile
75-05-8

acetonitrile

diethyl 2,2'-((1-(((4-(tert-butyl)phenyl)sulfonyl)imino)ethyl)azanediyl)(E)-diacetate

diethyl 2,2'-((1-(((4-(tert-butyl)phenyl)sulfonyl)imino)ethyl)azanediyl)(E)-diacetate

Conditions
ConditionsYield
With copper(II) bis(trifluoromethanesulfonate) at 80℃; for 2h;92%
diazoacetic acid ethyl ester
623-73-4

diazoacetic acid ethyl ester

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

acetonitrile
75-05-8

acetonitrile

C20H30N2O6S

C20H30N2O6S

Conditions
ConditionsYield
With copper(II) bis(trifluoromethanesulfonate) at 80℃; for 2h;92%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

(E)-N'-(4-tert-butylphenylsulfonyl)-N,N-dimethylformimidamide

(E)-N'-(4-tert-butylphenylsulfonyl)-N,N-dimethylformimidamide

Conditions
ConditionsYield
With thionyl chloride In chloroform at 60℃; for 3h;91%
8-methylquinoline
611-32-5

8-methylquinoline

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-(tert-butyl)-N-(quinolin-8-ylmethyl)benzenesulfonamide

4-(tert-butyl)-N-(quinolin-8-ylmethyl)benzenesulfonamide

Conditions
ConditionsYield
With silver hexafluoroantimonate; dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer; [bis(acetoxy)iodo]benzene; sodium acetate In dichloromethane at 20℃; for 48h; Inert atmosphere; Schlenk technique;89%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

C34H62O6Si

C34H62O6Si

C44H75NO7SSi

C44H75NO7SSi

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃; for 3h;87%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

C36H68O4Si2

C36H68O4Si2

C46H81NO5SSi2

C46H81NO5SSi2

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 20℃; for 3h;87%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

p-chlorphenylisocyanate
104-12-1

p-chlorphenylisocyanate

C17H19ClN2O3S
128924-62-9

C17H19ClN2O3S

Conditions
ConditionsYield
With sodium hydroxide In acetone86%
(4,4'-di-tert-butyl-2,2'-bipyridine)bis(trifluoromethanesulfonate)platinum(II)
177593-36-1

(4,4'-di-tert-butyl-2,2'-bipyridine)bis(trifluoromethanesulfonate)platinum(II)

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

lithium tetrakis(pentafluorophenyl)borate
2797-28-6

lithium tetrakis(pentafluorophenyl)borate

[(t-Bu2-2,2'-bipyridyl)Pt(μ-NHSO2C6H4Bu-t)]2[B(C6F5)4]2

[(t-Bu2-2,2'-bipyridyl)Pt(μ-NHSO2C6H4Bu-t)]2[B(C6F5)4]2

Conditions
ConditionsYield
In dichloromethane under inert atm. to Pt complex soln. ligand and excess Li(B(C6F5)4) in CH2Cl2 was added, mixt. was stirred at room temp. for 1 h; mixt. was filtered, evapd., solid was washed 3 times with ether, dried under vac. for 4 h; elem. anal.;86%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

cyclohexanone
108-94-1

cyclohexanone

4-(tert-butyl)-N-phenylbenzenesulfonamide

4-(tert-butyl)-N-phenylbenzenesulfonamide

Conditions
ConditionsYield
With 1,10-Phenanthroline; palladium(II) trifluoroacetate; oxygen In toluene at 140℃; for 40h;86%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4,6-dichloro-5-(2-methoxyphenyl)thiopyrimidine
374600-17-6

4,6-dichloro-5-(2-methoxyphenyl)thiopyrimidine

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenyl)thio-4-pyrimidinyl)benzenesulfonamide
167403-91-0

4-tert-butyl-N-(6-chloro-5-(2-methoxyphenyl)thio-4-pyrimidinyl)benzenesulfonamide

Conditions
ConditionsYield
With potassium carbonate In dimethyl sulfoxide at 80℃; for 1h;85%
morpholine
110-91-8

morpholine

4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

(E)-4-(tert-butyl)-N-(morpholinomethylene)benzenesulfonamide

(E)-4-(tert-butyl)-N-(morpholinomethylene)benzenesulfonamide

Conditions
ConditionsYield
With copper(I) bromide In dimethyl sulfoxide at 100℃; for 24h; Schlenk technique; stereoselective reaction;85%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

(Z)-1-{2-[4-(tert-butyl)phenylsulfonamido]phenyl}-2-phenyldiazene oxide

(Z)-1-{2-[4-(tert-butyl)phenylsulfonamido]phenyl}-2-phenyldiazene oxide

Conditions
ConditionsYield
With silver hexafluoroantimonate; dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer; [bis(acetoxy)iodo]benzene In 1,2-dichloro-ethane at 80℃; for 16h; regioselective reaction;84%
4-tert-butylbenzenesulphonamide
6292-59-7

4-tert-butylbenzenesulphonamide

4-(tert-butyl)benzene-1-sulfonyl fluoride

4-(tert-butyl)benzene-1-sulfonyl fluoride

Conditions
ConditionsYield
With potassium fluoride; pyrylium tetrafluoroborate; magnesium chloride In acetonitrile at 60℃; for 2h;84%

6292-59-7Relevant articles and documents

Unlocking Amides through Selective C–N Bond Cleavage: Allyl Bromide-Mediated Divergent Synthesis of Nitrogen-Containing Functional Groups

Govindan, Karthick,Chen, Nian-Qi,Chuang, Yu-Wei,Lin, Wei-Yu

supporting information, p. 9419 - 9424 (2021/11/30)

We report a new set of reactions based on the unlocking of amides through simple treatment with allyl bromide, creating a common platform for accessing a diverse range of nitrogen-containing functional groups such as primary amides, sulfonamides, primary amines, N-acyl compounds (esters, thioesters, amides), and N-sulfonyl esters. The method has potential industrial applicability, as demonstrated through gram-scale syntheses in batch and in a continuous flow system.

Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds

Pallesen, Jakob S.,Narayanan, Dilip,Tran, Kim T.,Solbak, Sara M. ?.,Marseglia, Giuseppe,S?rensen, Louis M. E.,H?j, Lars J.,Munafò, Federico,Carmona, Rosa M. C.,Garcia, Anthony D.,Desu, Haritha L.,Brambilla, Roberta,Johansen, Tommy N.,Popowicz, Grzegorz M.,Sattler, Michael,Gajhede, Michael,Bach, Anders

supporting information, p. 4623 - 4661 (2021/05/07)

Targeting the protein-protein interaction (PPI) between nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap1) is a potential therapeutic strategy to control diseases involving oxidative stress. Here, six classes of known small-molecule Keap1-Nrf2 PPI inhibitors were dissected into 77 fragments in a fragment-based deconstruction reconstruction (FBDR) study and tested in four orthogonal assays. This gave 17 fragment hits of which six were shown by X-ray crystallography to bind in the Keap1 Kelch binding pocket. Two hits were merged into compound 8 with a 220-380-fold stronger affinity (Ki = 16 μM) relative to the parent fragments. Systematic optimization resulted in several novel analogues with Ki values of 0.04-0.5 μM, binding modes determined by X-ray crystallography, and enhanced microsomal stability. This demonstrates how FBDR can be used to find new fragment hits, elucidate important ligand-protein interactions, and identify new potent inhibitors of the Keap1-Nrf2 PPI.

Sulfonamide compound and synthesis method and application thereof

-

Paragraph 0054-0057, (2019/04/02)

The invention discloses a synthesis method of a sulfonamide compound represented in a formula (2). According to the method, diazonium salt is used as a reaction raw material, and under the action of an inorganic nitrogen reagent, an inorganic sulfur dioxide reagent, an additive and a phosphine reagent, the diazonium salt is reacted in a solvent at 60-100 DEG C to obtain various sulfonamide compounds. According to the method inorganic salt is used as a nitrogen atom source and a sulfur dioxide source under a metal-free catalytic condition to construct the sulfonamide compound through one step,thereby avoiding the conventional multi-step synthesis of sulfonamide by condensing unstable acid chloride and amine; and the developed sulfonamide synthesis method can be further applied to the synthesis of the arthritis drug celecoxib and the psychotropic drug sulpiride.

Nickel complexes with phosphines and N-R-sulfonyldithiocarbimates ligands: New antifungals for the control of Hemileia vastatrix and Phakopsora pachyrhizi

Vidigal, Antonio E.C.,Rubinger, Mayura M.M.,de Queiroz, Luan F.,da Silva, Lucas F.,Zambolim, Laércio,Guilardi, Silvana,Souza, Rafael A.C.,Ellena, Javier,Wetler, Emiliana B.,Oliveira, Marcelo R.L.

, p. 724 - 732 (2018/12/11)

Nickel(II) complexes of general formula [Ni(RSO2N = CS2)(PPh3)2] (2a–h) or [Ni(RSO2N = CS2)dppe] (3a–h), where R = methyl (a), ethyl (b), butyl (c), octyl (d), phenyl (e), 4-isopropylphenyl (f), 4-tert-butylphenyl (g), 2-naphthyl (h), PPh3 = triphenylphosphine and dppe = 1,2-bis(diphenylphosphine)ethane were prepared, from which six are new substances (2f–h and 3f–h). The new compounds were characterized by elemental analysis of C, H, N and Ni, and by IR, UV–Vis and 1H, 13C and 31P NMR spectroscopies. The data were consistent with the formation of square planar nickel(II) complexes with mixed ligands, what was confirmed by single crystal X-ray diffraction studies on compounds 2f and 2h. These complexes present intramolecular Ni–H–C anagostic interactions. All complexes inhibited the germination of Hemileia vastatrix and Phakopsora pachyrhizi, the causal agents of devastating diseases on soybean and coffee cultures. The most active compounds presented IC90 values as low as 405 μM against H. vastatrix, and 280 μM against P. pachyrhizi. Thus, the title compounds are target molecules for the development of new agrochemicals against the Asian soybean rust and Coffee leaf-rust diseases.

Metal-free construction of primary sulfonamides through three diverse salts

Wang, Ming,Fan, Qiaoling,Jiang, Xuefeng

supporting information, p. 5469 - 5473 (2019/01/03)

In this report, the first metal-free construction of primary sulfonamides through a direct three-component reaction of sodium metabisulfite, sodium azide and aryldiazonium has been established. Readily available inorganic Na2S2O5 and NaN3 were applied as the sulfur dioxide surrogate and nitrogen source respectively. The widely used sulfonamide drugs Celecoxib and Sulpiride, which possess multiple heteroatoms and active hydrogen containing functional groups, are efficiently installed with -SO2NH2 groups at a late stage. Control experiments and kinetic studies demonstrated that aryl radicals, sulfonyl radicals and conjugated phosphine imine radicals are involved in this transformation.

Design, synthesis and biological evaluation of novel phenylsulfonylurea derivatives as PI3K/mTOR dual inhibitors

Zhao, Bingbing,Lei, Fei,Wang, Caolin,Zhang, Binliang,Yang, Zunhua,Li, Wei,Zhu, Wufu,Xu, Shan

, (2018/07/13)

Five series of novel phenylsulfonylurea derivatives, 19a–d, 20a–d, 21a–d, 22a–d and 23a–d, bearing 4-phenylaminoquinoline scaffold were designed, synthesized and their IC50 values against four cancer cell lines (HepG-2, A549, PC-3 and MCF-7) were evaluated. Most compounds showed moderate cytotoxicity activity against the cancer cell lines. Structure–activity relationships (SARs) and pharmacological results indicated that introduction of 4-aminoquinoline scaffold and phenylsulfonylurea scaffold were beneficial for anti-tumor activity. Moreover, para-methoxyl substitution of 4-anilino moiety and para-halogen substitution of phenylsulfonylurea have different impacts on different series of compounds. Furthermore, the micromolecule group substitution in the 6-position of the quinoline ring have a slight impact on the cellular activity of the target compounds.

Highly Chemoselective NH- and O-Transfer to Thiols Using Hypervalent Iodine Reagents: Synthesis of Sulfonimidates and Sulfonamides

Tota, Arianna,St John-Campbell, Sahra,Briggs, Edward L.,Estévez, Gala Ogalla,Afonso, Michelle,Degennaro, Leonardo,Luisi, Renzo,Bull, James A.

supporting information, p. 2599 - 2602 (2018/05/22)

Aryl thiols can be selectively converted to sulfonimidates or sulfonamides with three new S-X connections being made selectively in one pot. Using hypervalent iodine reagents in the presence of ammonium carbamate, NH- and O-groups are transferred under mild and practical conditions. Reducing the loading of ammonium carbamate changed the product distribution, converting the sulfonimidate to the sulfonamide. Studies into the possible intermediate species are presented, suggesting that multiple pathways may be possible via sulfinate esters, or related intermediates, with each species forming the same products.

Enabling the Cross-Coupling of Tertiary Organoboron Nucleophiles through Radical-Mediated Alkyl Transfer

Primer, David N.,Molander, Gary A.

supporting information, p. 9847 - 9850 (2017/08/02)

The construction of quaternary centers is a common challenge in the synthesis of complex materials and natural products. Current cross-coupling strategies that can be generalized for setting these centers are sparse and, when known, are typically predicated on the use of reactive organometallic reagents. To address this shortcoming a new, photoredox-Ni dual catalytic strategy for the cross-coupling of tertiary organoboron reagents with aryl halides is reported. In addition to details on the cross-coupling scope and limitations, full screening efforts and mechanistic experiments are communicated.

Discovery of novel DAPY-IAS hybrid derivatives as potential HIV-1 inhibitors using molecular hybridization based on crystallographic overlays

Huang, Boshi,Wang, Xueshun,Liu, Xinhao,Chen, Zihui,Li, Wanzhuo,Sun, Songkai,Liu, Huiqing,Daelemans, Dirk,De Clercq, Erik,Pannecouque, Christophe,Zhan, Peng,Liu, Xinyong

, p. 4397 - 4406 (2017/07/22)

Crystallographic overlap studies and pharmacophoric analysis indicated that diarylpyrimidine (DAPY)-based HIV-1 NNRTIs showed a similar binding mode and pharmacophoric features as indolylarylsulfones (IASs), another class of potent NNRTIs. Thus, a novel series of DAPY-IAS hybrid derivatives were identified as newer NNRTIs using structure-based molecular hybridization. Some target compounds exhibited moderate activities against HIV-1 IIIB strain, among which the two most potent inhibitors possessed EC50 values of 1.48?μM and 1.61?μM, respectively. They were much potent than the reference drug ddI (EC50?=?76.0?μM) and comparable to 3TC (EC50?=?2.54?μM). Compound 7a also exhibited the favorable selectivity index (SI?=?80). Preliminary structure-activity relationships (SARs), structure-cytotoxicity relationships, molecular modeling studies, and in silico calculation of physicochemical properties of these new inhibitors were also discussed.

Ruthenium trichloride catalyzed synthesis of 2,3-unsaturated-N-glycosides via Ferrier azaglycosylation

Reddy, Thurpu Raghavender,Chittela, Sravanthi,Kashyap, Sudhir

supporting information, p. 9224 - 9229 (2017/09/08)

An efficient, economical and mild protocol for the synthesis of 2,3-unsaturated-N-glycosides has been developed using ruthenium(III) chloride. The Ferrier azaglycosylation of glycals with various N-nucleophiles such as sulfonamides, benzamides, carbamates and N-substituted sulfonamides proceeded smoothly to afford the corresponding 2,3-unsaturated-N-glycosides or ‘N-pseudoglycals’ in good yields (64–98%). High α-anomeric selectivity was observed with N-substituted sulfonamides such as N-benzyl or N-phenyl sulfonamides under similar conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6292-59-7